TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 2 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,000 | -66.7% | 11,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $15,000 | +25.0% | 11,000 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $12,000 | -60.0% | 11,000 | 0.0% | 0.00% | -66.7% |
| Q3 2018 | $30,000 | -31.8% | 11,000 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $44,000 | -39.7% | 11,000 | +450.0% | 0.01% | -40.0% |
| Q1 2015 | $73,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |